ライフサイエンスコーパス: long-term nonprogressor

1 subjects with chronic HIV infection, and one long-term nonprogressor.

2 e antiretroviral therapy-treated patients or long term nonprogressors.

3 cted compared with both healthy controls and long-term nonprogressors.

4 ntrols, chronic HIV-1-infected patients, and long-term nonprogressors.

5 ents with acute HIV-1 infection but not from long-term nonprogressors.

6 essors, but much less frequently in aviremic long-term nonprogressors.

7 ly greater than previously observed in adult long-term nonprogressors.

8 odeficiency virus infection as well as HIV-1 long-term nonprogressors.

9 t observed in the minority of HIV-1-infected long-term nonprogressors.

10 ariants arise periodically in HIV-1-infected long-term nonprogressors.

11 human immunodeficiency virus (HIV)-infected long-term nonprogressors.

12 human immunodeficiency virus type 1-infected long-term nonprogressors.

13 Long-term nonprogressor AD-18 has been infected with hum

14 The high proportion of long-term nonprogressors among chronic lymphocytic leuke

15 Immunologic and genetic studies of long-term nonprogressors and exposed yet uninfected pers

16 Immunologic and genetic studies of long-term nonprogressors and exposed yet uninfected pers

17 e in most patients but have been reported in long-term nonprogressors and in patients treated with hi

18 Our results show that cocaine-using, long-term nonprogressors and normal progressors of HIV i

19 ls of DC-SIGN compared with cocaine-nonusing long-term nonprogressors and normal progressors, respect

20 e with progressive HIV disease compared with long-term nonprogressors and responders.

21 HIV-1-infected long-term nonprogressors are a heterogeneous group of in

22 a die before their third birthday (>89%) and long-term nonprogressors are rare.

23 es suggested that these patients, as well as long-term nonprogressors, are infected with defective HI

24 We further show that in a rare long-term nonprogressor, both an HIV-1-specific CD4(+)-T

25 irus infection of both progressor (BALB) and long term nonprogressor (C57BL) mouse strains is charact

26 induced CD4 down-modulation, and a subset of long-term nonprogressors carry viruses defective in this

27 rozygotes is increased among HIV-1- infected long-term nonprogressors compared with progressors; howe

28 Little activity was observed in sera from long-term nonprogressors (elite controllers).

29 77 miRNAs in CD4(+) T cells from HIV-1 elite long-term nonprogressors (eLTNPs), naive patients, and m

30 the Vpr mutant identified in HIV-1-infected long-term nonprogressors failed to promote TERT destabil

31 Long-term nonprogressors have high titer antibody respon

32 ting CD4(+) T cells in coinfected HLA-DR7(+) long-term nonprogressor HIV subjects with undetectable H

33 right) T cells are elevated in blood of HIV+ long-term nonprogressors in comparison to HIV- donors.

34 In a community-based cohort of HIV-2 long-term nonprogressors in rural Guinea-Bissau, we perf

35 A unique cohort of HIV-1-infected long term nonprogressors (LTNP) with normal CD4(+) T cel

36 progressor (P) and C57BL/10-H-2(k) (B10.BR) long-term nonprogressor (LTNP) mice.

37 iral loads in intestinal mucosal biopsies of long-term nonprogressor (LTNP) patients as compared to c

38 HIV replication in elite controller (EC) and long-term nonprogressor (LTNP) patients has been associa

39 Long-term nonprogressors (LTNP) and seronegative control

40 Undiluted sera from long-term nonprogressors (LTNP) had broad neutralizing a

41 ological clones from two progressors and two long-term nonprogressors (LTNP) in fetal thymic organ cu

42 ble immune-mediated control over HIV, termed long-term nonprogressors (LTNP) or elite controllers, an

43 VZV), and tetanus toxoid in normal controls, long-term nonprogressors (LTNP), and HIV-infected patien

44 (designated Rx <50) and untreated patients (long-term nonprogressors [LTNP]) matched for very low HI

45 fected subjects; the latter group included 8 long-term nonprogressors (LTNPs) and 17 progressors.

46 d in coculture by autologous CD8+ T cells in long-term nonprogressors (LTNPs) and in patients whose v

47 Seven long-term nonprogressors (LTNPs) have been identified in

48 Long-term nonprogressors (LTNPs) of human immunodeficien

49 HIV replication in rare individuals, termed long-term nonprogressors (LTNPs) or elite controllers.

50 virus (HIV type 1-infected, untreated white long-term nonprogressors (LTNPs) with a cohort of 605 HI

51 rol of human immunodeficiency virus (HIV) in long-term nonprogressors (LTNPs) with protective human l

52 +/- 74 in 11 healthy donors, 360 +/- 69 in 3 long-term nonprogressors (LTNPs), 186 +/- 52 in 9 newly

53 four patients including typical progressors, long-term nonprogressors (LTNPs), and vertically HIV-inf

54 human immunodeficiency virus (HIV)-infected long-term nonprogressors (LTNPs), it is also present at

55 has not yet been evaluated in HIV-1-infected long-term nonprogressors (LTNPs), who maintain high CD4(

56 True long-term nonprogressors (LTNPs)/elite controllers (ECs)

57 ects with a lack of disease progression (ie, long-term nonprogressors [LTNPs]) through 7 years of fol

58 Here we tested long-term nonprogressors' (LTNPs') susceptibility to sup

59 simian immunodeficiency virus (SIV)-infected long-term-nonprogressor macaque.

60 ntiretroviral therapy (n = 21), HIV-infected long-term nonprogressors (n = 10), and HIV-seronegative

61 naive (n = 63), elite controllers (n = 19), long-term nonprogressors (n = 7), and HIV-infected patie

62 previously seen in HIV-1-infected cohorts of long-term nonprogressors or patients with AIDS.

63 Long-term nonprogressors or slow progressors may remain

64 gous CD8+ cells from PBMCs from HIV-positive long-term nonprogressors; partial blocking of infection

65 In studies of long-term nonprogressors - persons who have stable CD4+

66 veral cohorts of HIV-1-infected individuals: long-term nonprogressors, progressors to disease, acute

67 disease progression and treatment, including long-term nonprogressors, progressors, and chronically i

68 cells to decrease virus burden, whereas the long term nonprogressor strains do not.

69 However, in a cohort of 33 HIV-1-infected long-term nonprogressors, those who were heterozygous fo

70 r AIDS Cohort Study, enriched with rapid and long-term nonprogressors to increase statistical power.

71 Unexpectedly, biologic clones from an adult long-term nonprogressor were noncytopathic in spite of s

72 An estimated 25-30% of long-term nonprogressors (who avoid clinical AIDS for 10

73 ins that were secreted when CD8 T cells from long-term nonprogressors with HIV-1 infection were stimu

74 ts were studied including a unique cohort of long-term nonprogressors with low levels of plasma viral

75 IV-specific CD8+ T cells were not limited to long-term nonprogressors with restriction of plasma viru

76 Furthermore, long-term nonprogressors with the wild-type CCR5 genotyp